MerTK tumorigenesis and immune evasion mechanisms in triple negative breast cancer

被引：0
|
作者：
Iida, Mari [1 ]
Kostecki, Kourtney [1 ]
Kranjac, Carlene A. [1 ]
Glitchev, Christine [1 ]
Yang, David T. [1 ]
Wheeler, Deric L. [1 ]
机构：
[1] Univ Wisconsin Madison, Madison, WI USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1334
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mechanisms of immune evasion in triple-negative breast cancer patients.
    Orozco, Javier Ignacio
    Manughian-Peter, Ayla O.
    Salomon, Matthew P.
    O'Day, Steven
    Hoon, Dave S. B.
    Marzese, Diego M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Procoagulant platelets promote immune evasion in triple-negative breast cancer
    Schaubaecher, Johanna B.
    Smiljanov, Bojan
    Haring, Florian
    Steiger, Katja
    Wu, Zhengquan
    Ugurluoglu, Anais
    Luft, Joshua
    Ballke, Simone
    Mahameed, Shaan
    Schneewind, Vera
    Hildinger, Jonas
    Canis, Martin
    Mittmann, Laura A.
    Braun, Constanze
    Zuchtriegel, Gabriele
    Kaiser, Rainer
    Nicolai, Leo
    Mack, Matthias
    Weichert, Wilko
    Lauber, Kirsten
    Uhl, Bernd
    Reichel, Christoph A.
    BLOOD, 2024, 144 (02) : 216 - 226
  • [3] Mechanisms of immune evasion in breast cancer
    Bates, Joshua P.
    Derakhshandeh, Roshanak
    Jones, Laundette
    Webb, Tonya J.
    BMC CANCER, 2018, 18
  • [4] Mechanisms of immune evasion in breast cancer
    Joshua P. Bates
    Roshanak Derakhshandeh
    Laundette Jones
    Tonya J. Webb
    BMC Cancer, 18
  • [5] Cancer stem cell markers allow for immune evasion in triple-negative breast cancer
    Hoffmann, Andrew D.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Interaction between VEGF-A and immune checkpoint targets in triple-negative breast cancer and mechanisms of immune evasion and tumor progression
    Seager, R. J.
    Pabla, Sarabjot
    Gandhi, Shipra
    Senosain, Maria-Fernanda
    Parikh, Hardik
    Van Roey, Erik
    Gao, Shuang
    Pulivendula, Yamuna
    DePietro, Paul
    Nesline, Mary K.
    Dash, Durga P.
    Conroy, Jeffrey M.
    Hastings, Stephanie B.
    Strickland, Kyle C.
    Previs, Rebecca A.
    Severson, Eric A.
    Caveney, Brian
    Jensen, Taylor J.
    Ramkissoon, Shakti H.
    Ko, Heidi Chwan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] MerTK as a putative biomarker for treatment response in triple negative breast cancer
    Mehall, Bridget E.
    Lida, Mad
    Kostecki, Kourtney L.
    Adams, Jillian M.
    Wheeler, Deric L.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [8] MerTK drives proliferation and metastasis activity in triple negative breast cancer
    Glitchev, Christine
    Iida, Mari
    Crossman, Bridget E.
    Kostecki, Kourtney L.
    Kranjac, Carlene A.
    Adams, Jillian M.
    Liu, Peng
    Ong, Irene
    Yang, David T.
    Kang, Irene
    Salgia, Ravi
    Wheeler, Deric L.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
    Cai, Wen-yu
    Cai, Xin-xian
    Fei, Yi-ran
    Ye, Rui
    Song, Ding-ming
    Hu, Dan
    Zhang, Wan-wan
    Xia, Ming-fei
    Yang, Xiao-xiao
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [10] Stromal cell diversity associated with immune evasion in human triple-negative breast cancer
    Wu, Sunny Z.
    Roden, Daniel L.
    Wang, Chenfei
    Holliday, Holly
    Harvey, Kate
    Cazet, Aurelie S.
    Murphy, Kendelle J.
    Pereira, Brooke
    Al-Eryani, Ghamdan
    Bartonicek, Nenad
    Hou, Rui
    Torpy, James R.
    Junankar, Simon
    Chan, Chia-Ling
    Lam, Chuan En
    Hui, Mun N.
    Gluch, Laurence
    Beith, Jane
    Parker, Andrew
    Robbins, Elizabeth
    Segara, Davendra
    Mak, Cindy
    Cooper, Caroline
    Warrier, Sanjay
    Forrest, Alistair
    Powell, Joseph
    O'Toole, Sandra
    Cox, Thomas R.
    Timpson, Paul
    Lim, Elgene
    Liu, X. Shirley
    Swarbrick, Alexander
    EMBO JOURNAL, 2020, 39 (19):
12345